Presentation TCT 2016 Direct Annuloplasty VI: Cardiac Implants Presenter: Ted Feldman, Scott Lim, Karl-Heinz Kuck October 31, 2016
Presentation TCT 2016 Controversy 3. Surgical Perspectives on Late Bioprosthetic Valve Durability Presenter: Raj Makkar, Lars Sondergaard, A. Pieter Kappetein October 31, 2016
Presentation TCT 2016 Direct Annuloplasty V: Valcare Presenter: Ted Feldman, Scott Lim, David Meerkin October 31, 2016
Presentation TCT 2016 Flash Debate: Counterpoint 4D-CT Leaflet Imaging Findings Will Help to Direct Anticoagulation Therapy! Presenter: Raj Makkar, Lars Sondergaard October 31, 2016
Presentation TCT 2016 Direct Annuloplasty IV: Millipede Presenter: Ted Feldman, Scott Lim, Jason H. Rogers October 31, 2016
Presentation TCT 2016 Flash Debate: Point 4D-CT Leaflet Thickening Is an Imaging Curiosity With No Clinical Relevance! Presenter: Raj Makkar, Lars Sondergaard, Ganesh Manoharan October 31, 2016
Presentation TCT 2016 Direct Annuloplasty III: Guided Delivery Systems Results, Device Iterations, and Future Directions Presenter: Ted Feldman, Scott Lim, Horst Sievert October 31, 2016
Presentation TCT 2016 Controversy 2. Global Clinical Trial Experiences on Bioprosthetic Leaflet Thickening/Thrombosis: Updates and Insights Presenter: Raj Makkar, Lars Sondergaard October 31, 2016
Presentation TCT 2016 Direct Annuloplasty II: Mitralign Trial Results and Future Directions Presenter: Ted Feldman, Scott Lim, Azeem Latib October 31, 2016
Presentation TCT 2016 Flash Debate: Counterpoint Cerebral Protection Is an Unnecessary and Costly Accessory! Presenter: Raj Makkar, Lars Sondergaard, Haim Danenberg October 31, 2016
Presentation TCT 2016 Direct Annuloplasty I: Cardioband TF Trial Results and Future Directions Presenter: Ted Feldman, Scott Lim, Francesco Maisano October 31, 2016
Presentation TCT 2016 Flash Debate: Point Cerebral Protection Is a Must for All Patients! Presenter: Raj Makkar, Lars Sondergaard, Axel Linke October 31, 2016
Presentation TCT 2016 Can Transcatheter Mitral Annuloplasty Provide a Long-term Solution for Secondary MR: Implications of the CTSN SMR Trial and Other Experiences Presenter: Ted Feldman, Scott Lim, Steven F. Bolling October 31, 2016
Presentation TCT 2016 Controversy 1. Is Cerebral Embolic Protection Needed for TAVR? The Evidence: Observations From DEFLECT 3, CLEAN-TAVI, and the SENTINEL Clinical Trials Presenter: Raj Makkar, Lars Sondergaard, Samir R. Kapadia October 31, 2016
Presentation TCT 2016 Next Generation MitraClip: Whats Better and Whats Not Presenter: Ted Feldman, Scott Lim, Ralph Stephan von Bardeleben October 31, 2016
Presentation TCT 2016 TCT 88: Innovative Transcatheter Tricuspid Valve Repair System. Initial Outcomes From the First in Human Multi-Centre Study Presenter: Alexander Lauten, Stephen G. Worthley, Paolo Denti October 31, 2016
Presentation TCT 2016 TCT 80: Characterizing the Incidence and Predictors of Paravalvular Regurgitation after Transcatheter Aortic Valve Replacement (TAVR) and its Impact on Outcomes: A Study of the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valv Presenter: John M. Lasala, Philippe Pibarot, Saif Anwaruddin October 31, 2016
Presentation TCT 2016 TCT 87: Transcatheter Treatment of Severe Tricuspid Regurgitation Using the MitraClip® System: 30-day Clinical Results in 13 Consecutive Patients. Presenter: Alexander Lauten, Stephen G. Worthley, Jörg Hausleiter October 31, 2016
Presentation TCT 2016 TCT 83: Transcatheter Aortic Valve Replacement With Different Valve Designs for Elliptic Aortic Annulus Shape Presenter: Mayra Guerrero, Roger J. Laham, Yoshio Maeno October 31, 2016
Presentation TCT 2016 TCT 79: Course of Early Subclinical Leaflet Thrombosis After Transcatheter Aortic Valve Replacement With or Without Oral Anticoagulation Presenter: John M. Lasala, Philippe Pibarot, Jürgen Rothe October 31, 2016